Giovanna B. Colan

Array ( [id] => 8586883 [patent_doc_number] => 20130005704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/337216 [patent_app_country] => US [patent_app_date] => 2011-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74133 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13337216 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312552 [patent_doc_number] => 20120189576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => '3\'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2\'-HYDROXY-[1,1\'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)' [patent_app_type] => utility [patent_app_number] => 13/334770 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2574 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8043883 [patent_doc_number] => 20120071683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-22 [patent_title] => 'New Process' [patent_app_type] => utility [patent_app_number] => 13/232020 [patent_app_country] => US [patent_app_date] => 2011-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4755 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20120071683.pdf [firstpage_image] =>[orig_patent_app_number] => 13232020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056091 [patent_doc_number] => 20120077779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Inhibitors of Fibroblast Activation Protein Alpha' [patent_app_type] => utility [patent_app_number] => 13/177268 [patent_app_country] => US [patent_app_date] => 2011-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8136 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077779.pdf [firstpage_image] =>[orig_patent_app_number] => 13177268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8567314 [patent_doc_number] => 20120329885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'Ultraviolet light absorbing compounds based on benzyl substituted 2-(2- hydroxyphenyl) benzotriazoles' [patent_app_type] => utility [patent_app_number] => 13/135020 [patent_app_country] => US [patent_app_date] => 2011-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8576 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13135020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8523585 [patent_doc_number] => 20120322993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-20 [patent_title] => 'Phosphorylation Reagent' [patent_app_type] => utility [patent_app_number] => 13/521156 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7501 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8490300 [patent_doc_number] => 20120289706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'Method for Producing Triazolinthione Derivatives and Intermediates Thereof' [patent_app_type] => utility [patent_app_number] => 13/515064 [patent_app_country] => US [patent_app_date] => 2010-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24844 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574300 [patent_doc_number] => 20110269956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Hepatitis C Virus Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/915605 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 191616 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269956.pdf [firstpage_image] =>[orig_patent_app_number] => 12915605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5935870 [patent_doc_number] => 20110212054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'THROMBOPOIETIN MIMETICS' [patent_app_type] => utility [patent_app_number] => 12/849147 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15194 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212054.pdf [firstpage_image] =>[orig_patent_app_number] => 12849147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302193 [patent_doc_number] => 20120184751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'POLYMORPHIC FORM OF OLMESARTAN MEDOXOMIL' [patent_app_type] => utility [patent_app_number] => 13/388091 [patent_app_country] => US [patent_app_date] => 2010-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 2096 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8302191 [patent_doc_number] => 20120184750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL' [patent_app_type] => utility [patent_app_number] => 13/321231 [patent_app_country] => US [patent_app_date] => 2010-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2695 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140827 [patent_doc_number] => 20120094963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'TARGETING PRODRUGS AND COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES' [patent_app_type] => utility [patent_app_number] => 13/141663 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11758 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094963.pdf [firstpage_image] =>[orig_patent_app_number] => 13141663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490171 [patent_doc_number] => 20110237528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'COMPOSITIONS AND METHODS COMPRISING IMIDAZOLE AND TRIAZOLE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/119941 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47003 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237528.pdf [firstpage_image] =>[orig_patent_app_number] => 13119941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186671 [patent_doc_number] => 20110124692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'CRYSTALLINE FORMS OF THIAZOLIDINEDIONE COMPOUND AND ITS MANUFACTURING METHOD' [patent_app_type] => utility [patent_app_number] => 13/056648 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14060 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124692.pdf [firstpage_image] =>[orig_patent_app_number] => 13056648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142130 [patent_doc_number] => 20110129455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'INHIBITORS OF AKT ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/999505 [patent_app_country] => US [patent_app_date] => 2009-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16811 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129455.pdf [firstpage_image] =>[orig_patent_app_number] => 12999505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944842 [patent_doc_number] => 20110105462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'MODULATORS OF DOPAMINE NEUROTRANSMISSION' [patent_app_type] => utility [patent_app_number] => 12/990059 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23420 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105462.pdf [firstpage_image] =>[orig_patent_app_number] => 12990059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102867 [patent_doc_number] => 20110166360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Catalytic Process for Asymmetric Hydrogenation' [patent_app_type] => utility [patent_app_number] => 12/921961 [patent_app_country] => US [patent_app_date] => 2009-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7919 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166360.pdf [firstpage_image] =>[orig_patent_app_number] => 12921961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267549 [patent_doc_number] => 20100298381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'GAMMA SECRETASE MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/676035 [patent_app_country] => US [patent_app_date] => 2008-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36414 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298381.pdf [firstpage_image] =>[orig_patent_app_number] => 12676035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453353 [patent_doc_number] => 20090069390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'DEUTERIUM-ENRICHED RUFINAMIDE' [patent_app_type] => utility [patent_app_number] => 12/203487 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2878 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069390.pdf [firstpage_image] =>[orig_patent_app_number] => 12203487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6428906 [patent_doc_number] => 20100168421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'A NEW PEPTIDE DEFORMYLASE INHIBITOR COMPOUND AND MANUFACTURING PROCESS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/663316 [patent_app_country] => US [patent_app_date] => 2008-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17437 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168421.pdf [firstpage_image] =>[orig_patent_app_number] => 12663316 [rel_patent_id] =>[rel_patent_doc_number] =>)